Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Integral Diagnostics Ltd. ( (AU:IDX) ) just unveiled an announcement.
Integral Diagnostics Ltd has issued 99,221 new fully paid ordinary shares on 22 December 2025 following the exercise or conversion of previously unquoted options or other convertible securities. The move modestly increases the company’s share base and reflects the take-up of equity incentives by holders of these instruments, slightly diluting existing shareholders while converting unquoted rights into listed equity.
The most recent analyst rating on (AU:IDX) stock is a Sell with a A$2.10 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Average Trading Volume: 979,263
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$898.8M
For a thorough assessment of IDX stock, go to TipRanks’ Stock Analysis page.